EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pia Mater‐Penetrable Lipopolymer Nanoparticles for Gliocyte‐Targeted IL‐10 mRNA Therapy Alleviate Paclitaxel‐Induced Peripheral Neuropathy

Xinrou Lin, Lingyu Wei, Xiangpen Li, Ling Zeng, Yingsen Tang, Hongjin Wang, Hengjian Lu, Chenguang Li, Hongxuan Wang, Jinjin Chen, Ying Peng iD

Advanced Science · 2025

DOI: 10.1002/advs.202500362 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Xinrou Lin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510000, China. Hauptthemen laut MEDLINE: Paclitaxel, Nanoparticles, Peripheral Nervous System Diseases, RNA, Messenger. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China and Germany Collaboration & Exchange Project, National Natural Science Foundation of China, National Key R&D Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Paclitaxel (PTX) is a commonly used chemotherapeutic agent for treating various solid tumors; however, it often leads to a severe side effect known as paclitaxel‐induced peripheral neuropathy (PIPN), for which effective treatments are limited. Although mRNA therapies have shown promise in addressing central nervous system (CNS) disorders, the successful delivery of mRNA therapeutics to the nervous system is still hindered by many biological barriers. In this study, it is demonstrated that, compared with commercial MC3 lipid nanoparticles (MC3 LNPs), mRNA‐loaded P6CIT‐derived lipopolymer nanoparticles (P6CIT LPNPs), which are delivered via intrathecal injection, achieve effective penetration through the pia mater. More importantly, this P6CIT LPNP demonstrates the ability to achieve highly targeted mRNA transfection in gliocytes within the spinal cord and dorsal root ganglia (DRG), which is essential for the regulation of neuroinflammation. Furthermore, two intrathecal injections of P6CIT LPNPs encapsulating mIL‐10 (P6CIT/mIL‐10) significantly alleviate PIPN by reducing proinflammatory cytokine production, gliocyte activation, and presynaptic NMDA receptor hyperactivity in both male and female mice. This study presents a promising and clinically translatable platform for using mRNA‐loaded LPNPs to treat PIPN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PaclitaxelNanoparticlesPeripheral Nervous System DiseasesRNA, MessengerInterleukin-10NeurogliaAnimalsMiceMaleGanglia, SpinalFemale

Stichwörter der Autor:innen

IL‐10dorsal root ganglionlipopolymer nanoparticlemRNApaclitaxel‐induced peripheral neuropathy

Substanzen

PaclitaxelRNA, MessengerInterleukin-10

Autor:innen und Institutionen

  • Department of Neurology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510000, China.
  • Nanhai Translational Innovation Center of Precision Immunology, Sun Yat-Sen Memorial Hospital, Foshan, 528200, China.
  • Department of Anesthesiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510000, China.
  • Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510000, China.
  • Shenshan Medical Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Shanwei, 516600, China.
  • Department of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510000, China.

ORCID-Profile: Ying Peng

Förderung

  • China and Germany Collaboration & Exchange Project
  • National Natural Science Foundation of China
  • National Key R&D Program of China
  • National Key Research and Development Program of China

Zitieren

APA

Lin, X., Wei, L., Li, X., Zeng, L., Tang, Y., Wang, H., Lu, H., Li, C., Wang, H., Chen, J., & Peng, Y. (2025). Pia Mater‐Penetrable Lipopolymer Nanoparticles for Gliocyte‐Targeted IL‐10 mRNA Therapy Alleviate Paclitaxel‐Induced Peripheral Neuropathy. Advanced Science. https://doi.org/10.1002/advs.202500362

Vancouver

Lin X, Wei L, Li X, Zeng L, Tang Y, Wang H, et al. Pia Mater‐Penetrable Lipopolymer Nanoparticles for Gliocyte‐Targeted IL‐10 mRNA Therapy Alleviate Paclitaxel‐Induced Peripheral Neuropathy. Advanced Science. 2025. doi:10.1002/advs.202500362

BibTeX
@article{Lin2025,
  author = {Lin, Xinrou and Wei, Lingyu and Li, Xiangpen and Zeng, Ling and Tang, Yingsen and Wang, Hongjin and Lu, Hengjian and Li, Chenguang and Wang, Hongxuan and Chen, Jinjin and Peng, Ying},
  title = {Pia Mater‐Penetrable Lipopolymer Nanoparticles for Gliocyte‐Targeted IL‐10 mRNA Therapy Alleviate Paclitaxel‐Induced Peripheral Neuropathy},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202500362}
}
Kostenlos starten →